Healthcare / Medical Care FacilitiesSaudi
$121.30
-1.20 (-0.98%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 26% · confianza 25%
FCF escenarios
weak_data · normalized FCF $-215.1M · quality 56.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
32/100
D
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
12/100
SEC 0%
Sin guardar todavía.
Market Cap
$5.4B
P/E
28.1x
↑EV/EBITDA
17.0x
↑ROE
12.3%
↑Gross Margin
31.7%
↓Debt/Equity
0.42
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2023–2025 · 2 años de histórico normalizado
Revenue CAGR
—
FCF CAGR
—
FCF margin
-24.7%
FCF / Net income
-1.48x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $1.42B · net income $236.5M · FCF $-350.2M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | $1.42B | $1.42B | $1.20B | — |
| Net Income | $236.5M | $236.5M | $49.4M | — |
| EBITDA | $361.0M | $361.0M | $226.4M | — |
| EPS | 5.36 | 5.36 | 1.11 | — |
| Gross Margin | 31.7% | 31.7% | 30.9% | — |
| Operating Margin | 14.5% | 14.5% | 14.2% | — |
| Net Margin | 16.7% | 16.7% | 4.1% | — |
| Balance Sheet | ||||
| Debt/Equity | 0.42 | 0.42 | 2.16 | 2.00 |
| Current Ratio | 1.71 | 1.71 | — | — |
| Cash Flow | ||||
| Free Cash Flow | $-350.2M | $-350.2M | $-79.9M | — |
| Returns | ||||
| ROE | 12.3% | 12.3% | 7.9% | — |
| Valuation | ||||
| P/E | 28.14 | 28.14 | 120.11 | — |
| EV/EBITDA | 16.98 | 16.98 | 31.99 | — |
| P/B | 2.78 | 2.78 | 9.47 | — |
| Growth & Yield | ||||
| Revenue Growth | 17.8% | 17.8% | — | — |
| EPS Growth | 381.2% | 381.2% | — | — |
| Dividend Yield | 0.8% | 0.8% | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
26.2%
EPS terminal req.
$10.76
Spread vs growth
355.0%
5Y implied EPS CAGR
19.4%
EPS terminal req.
$13.02
Spread vs growth
361.7%
10Y implied EPS CAGR
14.6%
EPS terminal req.
$20.97
Spread vs growth
366.5%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-21.4%
Start / end P/E
140.0x → 22.6x
EPS bridge
1.11 → 5.36
Residual
-319.6%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.